• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    AGC Biologics Appoints Jun Takami GM of Chiba Site
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Ascendia Pharmaceuticals Poised for Expansion

    Bora Pharmaceuticals Adds Roller Compaction Capabilities

    Alkermes, Merck Enter Clinical Trial and Supply Agreement

    Sterling Pharma Solutions Acquires ADC Biotechnology

    Moderna, Catalent Enter Long-Term Strategic Vax Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success

    Enteris BioPharma: Custom Solutions – From Bench to Market

    The Benefits of Outsourcing Cold Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

    Ascendia Pharmaceuticals Poised for Expansion

    Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

    Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

    Alkermes, Merck Enter Clinical Trial and Supply Agreement
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market

    Metrics Contract Services Completes Russian Regulatory Inspection
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Aphena Pharma Solutions

    Alcami

    Almac Group

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Almac Group

    Reed-Lane

    Aphena Pharma Solutions

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    UPM Celebrates 100-Years of Mfg. at Tennessee Site

    Bristol facility grows from a $25 hand-operated tablet machine to a 500,000 square-foot campus

    UPM Celebrates 100-Years of Mfg. at Tennessee Site
    Related CONTENT
    • Vetio Animal Health
    • UPM Pharmaceuticals
    • Thermo Fisher Buys Patheon for $7.2B
    • Sharp Acquires Daiichi Sankyo Inc.’s Pharmaceutical Packaging Facility in Bethlehem, PA
    • Domain, Pfizer in bioSensAll Alliance
    05.17.17
    UPM Pharmaceuticals is celebrating the 100-year anniversary of pharmaceutical manufacturing occurring at its Bristol, TN, facility. Pharmaceutical products have been continuously manufactured at its current site since 1917.

    In March 1917, S.E. Massengill purchased the site and transformed it into a pharmaceutical manufacturing facility. According to historical records, the Massengill brothers purchased their first piece of manufacturing equipment, a $25 hand-operated tablet machine and began the legacy. In 1971 the site became home to Beecham Laboratories’ North American headquarters. King Pharmaceuticals acquired the site in 1993, which was then sold to Pfizer in 2011. In July 2013 UPM bought the facility from Pfizer.

    UPM is an independent contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology industries.

    During the 100 years of production at the Bristol site, operations have expanded from a small facility footprint of less than 10,000 square feet and only two small buildings, to a modern campus of over 475,000 square feet and additional warehouse and distribution space of almost 250,000 square feet.

    “We are proud of the legacy of the Bristol, TN, site in the history of the pharmaceutical industry,” said James Gregory, chief executive officer, UPM. “The success of the products and the growth of the capabilities of the site stand as testimony to the many outstanding employees who have worked here over the past century."

    UPM Pharmaceuticals originated as a drug formulation and cGMP laboratory within the University of Maryland School of Pharmacy, and today offers a full breadth of capabilities from early research and development to clinical trial material manufacturing and commercial scale product supply. It is also DEA approved to handle CII-CV manufacturing. The Bristol site has several low humidity manufacturing suites and the ability to handle potent compounds in dedicated suites.

    The last FDA audit at the site was in October 2016. It was a general GMP inspection of all systems and a preapproval inspection of a product that the company’s R&D team developed. No 483s were issued and approval of the site to manufacture the product was recommended.

    “Obviously, we were quite proud of this result,” said Mr. Gregory. “We also have yearly DEA inspections given our capabilities to handle controlled substance products and have had no notice of violations or 'for cause' investigations. UPM is fully committed to quality and manufacturing innovations to assure the timely supply of needed medicines."

    According to the company, a new, proactive approach to quality was adopted in 2016 that is client-focused and includes implementation of manufacturing quality assurance (MQA), the use of metrics to evaluate performance and realignment of its laboratory functions to increase both efficiency and responsiveness.
    Related Searches
    • CDMO
    • GMP
    • Development
    • Clinical Trial
    Suggested For You
    Vetio Animal Health Vetio Animal Health
    UPM Pharmaceuticals UPM Pharmaceuticals
    Thermo Fisher Buys Patheon for $7.2B Thermo Fisher Buys Patheon for $7.2B
    Sharp Acquires Daiichi Sankyo Inc.’s Pharmaceutical Packaging Facility in Bethlehem, PA Sharp Acquires Daiichi Sankyo Inc.’s Pharmaceutical Packaging Facility in Bethlehem, PA
    Domain, Pfizer in bioSensAll Alliance   Domain, Pfizer in bioSensAll Alliance
    Quality Risk Management Quality Risk Management
    Sharp Packaging Services Expands U.S. and UK Ops  Sharp Packaging Services Expands U.S. and UK Ops
    Newsmakers: Peter Soelkner Newsmakers: Peter Soelkner
    Pfizer CentreOne Expands Service Portfolio Pfizer CentreOne Expands Service Portfolio
    Trends in Pharma Analysis Trends in Pharma Analysis
    Solubility Enhancement: Novel Approaches to Rational Formulation Choice Solubility Enhancement: Novel Approaches to Rational Formulation Choice
    Pfizer CentreOne Expands Fill-Finish Services Pfizer CentreOne Expands Fill-Finish Services
    Financial Report: Pfizer Financial Report: Pfizer
    API Makers Speed Expansion API Makers Speed Expansion
    Amatsigroup Acquires Disposable-Lab Amatsigroup Acquires Disposable-Lab

    Related Breaking News

    • Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
      Bora Pharmaceuticals Adds Roller Compaction Capabilities

      Bora Pharmaceuticals Adds Roller Compaction Capabilities

      Installed at Zhunan, Taiwan facility known for manufacturing complex oral solid dose formulations.
      Tim Wright, Editor, Contract Pharma 04.09.21

    • Analytical Services | Breaking News | Clinical Trial Materials | Drug Development | Industry News
      Ascendia Pharmaceuticals Poised for Expansion

      Ascendia Pharmaceuticals Poised for Expansion

      CDMO secures growth equity investment from Signet Healthcare Partners.
      Tim Wright, Editor, Contract Pharma 04.09.21

    • Breaking News | Clinical Trials | CRO News | Industry News
      Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

      Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ

      Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.
      Tim Wright, Editor, Contract Pharma 04.09.21


    • Breaking News | Clinical Trials | CRO News
      Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

      Merck KGaA Selects PRA’s Remote Patient Monitoring Platform

      Adding layer of technology to HGH treatments aims to facilitate better patient compliance.
      Kristin Brooks 04.08.21

    • Breaking News | Promotions & Moves
      AGC Biologics Appoints Jun Takami GM of Chiba Site

      AGC Biologics Appoints Jun Takami GM of Chiba Site

      Mr. Takami brings more than 15 years of experience in the pharmaceutical industry.
      Kristin Brooks 04.08.21

    • Analytical Services | Bioanalytical Services | Breaking News | Industry News
      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Agilex Biolabs Acquires TetraQ for APAC Expansion Plans

      Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.
      Kristin Brooks 04.08.21


    • Breaking News | Promotions & Moves
      Imvax Appoints Sean Hemingway Chief Operating Officer

      Imvax Appoints Sean Hemingway Chief Operating Officer

      Hemingway brings more than 25 years of experience in biological manufacturing and supply chain.
      Kristin Brooks 04.08.21

    • Breaking News | Industry News | Promotions & Moves
      Legacy Pharma Solutions Appoints President

      Legacy Pharma Solutions Appoints President

      Promotes Brad Rayner, a 17-year executive of the pharmaceutical industry.
      Charles Sternberg, Assistant Editor 04.07.21

    • Breaking News | Industry News
      ANI Acquires Branded Products Portfolio from Sandoz

      ANI Acquires Branded Products Portfolio from Sandoz

      Enter multi-year manufacturing and supply agreement.
      Charles Sternberg, Assistant Editor 04.07.21


    • Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
      Alkermes, Merck Enter Clinical Trial and Supply Agreement

      Alkermes, Merck Enter Clinical Trial and Supply Agreement

      To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.
      Tim Wright, Editor, Contract Pharma 04.07.21

    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals

      Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.
      Tim Wright, Editor, Contract Pharma 04.07.21

    • Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
      Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate

      Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate

      Work together to develop and commercialize CHI’s novel dry-powder inhaler product.
      Charles Sternberg, Assistant Editor 04.07.21


    • Bio News | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
      Sterling Pharma Solutions Acquires ADC Biotechnology

      Sterling Pharma Solutions Acquires ADC Biotechnology

      Will establish a center of excellence for bioconjugation and ADC development and manufacturing services.
      Tim Wright, Editor, Contract Pharma 04.07.21

    • Breaking News | Clinical Trials | Drug Development | Industry News
      Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment

      Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment

      To support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of COVID-19.
      Kristin Brooks 04.06.21

    • Breaking News | Clinical Trials | CRO News | Drug Development
      Moleculin Selects IQVIA Biotech to Advance COVID Treatment

      Moleculin Selects IQVIA Biotech to Advance COVID Treatment

      IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.
      Kristin Brooks 04.06.21

    Trending
    • Sterling Pharma Solutions Acquires ADC Biotechnology
    • Ascendia Pharmaceuticals Poised For Expansion
    • Sanofi To Build New $700M Flu Vaccine Facility In Canada
    • Frontage Expands Capabilities At Its Clinical Site In Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    Breaking News
    • Bora Pharmaceuticals Adds Roller Compaction Capabilities
    • Ascendia Pharmaceuticals Poised for Expansion
    • Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    • Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
    • AGC Biologics Appoints Jun Takami GM of Chiba Site
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login